RETRACTED ARTICLE: Overexpression of microRNA-202-3p protects against myocardial ischemia-reperfusion injury through activation of TGF-β1/Smads signaling pathway by targeting TRPM6

We, the Editors and Publisher of the journal <i>Cell Cycle</i>, have retracted the following article: Hui-Ying Wu, Jian-Li Wu, and Zhan-Ling Ni. Overexpression of microRNA-202-3p protects against myocardial ischemia-reperfusion injury through activation of TGF-β1/Smads signaling pathway by targeting TRPM6. Cell Cycle. 2019;18(5):621-637. doi: 10.1080/15384101.2019.1580494. Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors have been unable to address the concerns raised and have not been able to provide their original data or supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed. We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

《细胞周期》（Cell Cycle）期刊的编辑与出版方已撤回以下文章：吴慧英、吴建利、倪占玲。《过表达微小RNA-202-3p（microRNA-202-3p）通过靶向TRPM6激活转化生长因子-β1/Smads（TGF-β1/Smads）信号通路减轻心肌缺血再灌注损伤》。发表于《细胞周期》，2019年；18(5):621-637。DOI: 10.1080/15384101.2019.1580494。
该文章发表后，有读者对其数据的真实性与完整性提出质疑。当期刊向作者索要解释时，作者未能回应相关质疑，亦无法提供原始实验数据及支撑性材料。由于验证已发表研究的有效性是维护学术记录可信度的核心要义，因此我方决定撤回该文章。本文所列通讯作者已收到通知。
本次撤稿决策依据我方出版伦理与诚信政策以及国际出版伦理委员会（COPE）的撤稿指南制定。